Oct 3 (Reuters) - Celgene Corp :
* Provides update on FDA advisory committee for Pomalidomide
* Notified by the U.S. FDA there will not be oncologic drugs advisory committee
meeting scheduled for November 8, 2012
* FDA informed co review of nda for Pomalidomide continuing with PDUFA action
date remaining February 10, 2013
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
((For more news, please click here ))